This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slipped 5.9% to $1.93 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.0% to 17,303.01 and Dow Jones Industrial Average falling 1.3% to 40,813.57.
Inovio Pharmaceuticals Inc. closed 86.9% short of its 52-week high of $14.75, which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.1% to $162.99, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.43% to $25.60.
Trading volume totaled 394,551, compared to the 50-day average of 875,171.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 13, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.